X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs PLETHICO PHARMA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER PLETHICO PHARMA PFIZER/
PLETHICO PHARMA
 
P/E (TTM) x 30.4 -1.1 - View Chart
P/BV x 5.2 0.0 30,794.0% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 PFIZER   PLETHICO PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-16
PLETHICO PHARMA
Mar-14
PFIZER/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs2,724395 689.8%   
Low Rs1,61131 5,147.0%   
Sales per share (Unadj.) Rs440.9604.4 72.9%  
Earnings per share (Unadj.) Rs48.732.5 149.9%  
Cash flow per share (Unadj.) Rs75.851.3 147.6%  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs462.9473.6 97.8%  
Shares outstanding (eoy) m45.7534.08 134.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.90.4 1,394.4%   
Avg P/E ratio x44.56.6 678.4%  
P/CF ratio (eoy) x28.64.2 689.0%  
Price / Book Value ratio x4.70.5 1,040.4%  
Dividend payout %30.80-   
Avg Mkt Cap Rs m99,1637,262 1,365.4%   
No. of employees `0002.9NA-   
Total wages/salary Rs m2,7581,596 172.8%   
Avg. sales/employee Rs Th6,981.7NM-  
Avg. wages/employee Rs Th954.5NM-  
Avg. net profit/employee Rs Th771.1NM-  
INCOME DATA
Net Sales Rs m20,17020,598 97.9%  
Other income Rs m857386 221.9%   
Total revenues Rs m21,02820,984 100.2%   
Gross profit Rs m4,3102,818 153.0%  
Depreciation Rs m1,239642 192.9%   
Interest Rs m51,593 0.3%   
Profit before tax Rs m3,923969 405.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794-138 -1,296.7%   
Profit after tax Rs m2,2281,107 201.3%  
Gross profit margin %21.413.7 156.2%  
Effective tax rate %45.7-14.3 -320.1%   
Net profit margin %11.05.4 205.5%  
BALANCE SHEET DATA
Current assets Rs m16,29918,877 86.3%   
Current liabilities Rs m7,59411,896 63.8%   
Net working cap to sales %43.233.9 127.3%  
Current ratio x2.11.6 135.3%  
Inventory Days Days6536 181.6%  
Debtors Days Days26198 13.0%  
Net fixed assets Rs m8,6229,861 87.4%   
Share capital Rs m458341 134.3%   
"Free" reserves Rs m20,72212,331 168.1%   
Net worth Rs m21,18016,139 131.2%   
Long term debt Rs m254,706 0.5%   
Total assets Rs m29,13733,146 87.9%  
Interest coverage x755.51.6 46,985.7%   
Debt to equity ratio x00.3 0.4%  
Sales to assets ratio x0.70.6 111.4%   
Return on assets %7.78.1 94.1%  
Return on equity %10.56.9 153.4%  
Return on capital %19.012.3 154.5%  
Exports to sales %0.121.4 0.3%   
Imports to sales %17.515.2 114.8%   
Exports (fob) Rs m124,402 0.3%   
Imports (cif) Rs m3,5263,136 112.4%   
Fx inflow Rs m524,402 1.2%   
Fx outflow Rs m1403,184 4.4%   
Net fx Rs m-881,219 -7.2%   
CASH FLOW
From Operations Rs m3,4362,437 141.0%  
From Investments Rs m-6,991-6,265 111.6%  
From Financial Activity Rs m-6192,490 -24.9%  
Net Cashflow Rs m-4,174-1,337 312.1%  

Share Holding

Indian Promoters % 0.0 82.7 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 4.3 174.4%  
FIIs % 4.9 5.5 89.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 7.5 316.0%  
Shareholders   85,207 10,665 798.9%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ORCHID PHARMA LTD  WYETH LTD  TORRENT PHARMA  ALEMBIC LTD  CIPLA  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Extends Losses; Pharma Stocks Top Losers(Closing)

After opening the day in red share markets in India witnessed negative trading activity throughout the day, and ended well below the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


May 21, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS